In a first line genetic screening for SCA1, SCA2, SCA3, SCA6, SCA7 and SCA17 mutations 440 ataxia patients were tested negative, as requested through clinical neurologists or other specialists. The gene discussed is ATXN3; the disease is Ataxia.